BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 32945427)

  • 1. Association between serum anti‑ASXL2 antibody levels and acute ischemic stroke, acute myocardial infarction, diabetes mellitus, chronic kidney disease and digestive organ cancer, and their possible association with atherosclerosis and hypertension.
    Li SY; Yoshida Y; Kobayashi E; Adachi A; Hirono S; Matsutani T; Mine S; Machida T; Ohno M; Nishi E; Maezawa Y; Takemoto M; Yokote K; Kitamura K; Sumazaki M; Ito M; Shimada H; Takizawa H; Kashiwado K; Tomiyoshi G; Shinmen N; Nakamura R; Kuroda H; Zhang XM; Wang H; Goto K; Iwadate Y; Hiwasa T
    Int J Mol Med; 2020 Oct; 46(4):1274-1288. PubMed ID: 32945427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum anti-LRPAP1 is a common biomarker for digestive organ cancers and atherosclerotic diseases.
    Sumazaki M; Shimada H; Ito M; Shiratori F; Kobayashi E; Yoshida Y; Adachi A; Matsutani T; Iwadate Y; Mine S; Machida T; Kamitsukasa I; Mori M; Sugimoto K; Uzawa A; Kuwabara S; Kobayashi Y; Ohno M; Nishi E; Maezawa Y; Takemoto M; Yokote K; Takizawa H; Kashiwado K; Shin H; Kishimoto T; Matsushita K; Kobayashi S; Nakamura R; Shinmen N; Kuroda H; Zhang XM; Wang H; Goto KI; Hiwasa T
    Cancer Sci; 2020 Dec; 111(12):4453-4464. PubMed ID: 32939876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum anti-DIDO1, anti-CPSF2, and anti-FOXJ2 antibodies as predictive risk markers for acute ischemic stroke.
    Hiwasa T; Wang H; Goto KI; Mine S; Machida T; Kobayashi E; Yoshida Y; Adachi A; Matsutani T; Sata M; Yamagishi K; Iso H; Sawada N; Tsugane S; Kunimatsu M; Kamitsukasa I; Mori M; Sugimoto K; Uzawa A; Muto M; Kuwabara S; Kobayashi Y; Ohno M; Nishi E; Hattori A; Yamamoto M; Maezawa Y; Kobayashi K; Ishibashi R; Takemoto M; Yokote K; Takizawa H; Kishimoto T; Matsushita K; Kobayashi S; Nomura F; Arasawa T; Kagaya A; Maruyama T; Matsubara H; Tomiita M; Hamanaka S; Imai Y; Nakagawa T; Kato N; Terada J; Matsumura T; Katsumata Y; Naito A; Tanabe N; Sakao S; Tatsumi K; Ito M; Shiratori F; Sumazaki M; Yajima S; Shimada H; Shirouzu M; Yokoyama S; Kudo T; Doi H; Iwase K; Ashino H; Li SY; Kubota M; Tomiyoshi G; Shinmen N; Nakamura R; Kuroda H; Iwadate Y
    BMC Med; 2021 Jun; 19(1):131. PubMed ID: 34103026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum anti-AP3D1 antibodies are risk factors for acute ischemic stroke related with atherosclerosis.
    Li SY; Yoshida Y; Kobayashi E; Kubota M; Matsutani T; Mine S; Machida T; Maezawa Y; Takemoto M; Yokote K; Kobayashi Y; Takizawa H; Sata M; Yamagishi K; Iso H; Sawada N; Tsugane S; Kobayashi S; Matsushita K; Nomura F; Matsubara H; Sumazaki M; Ito M; Yajima S; Shimada H; Iwase K; Ashino H; Wang H; Goto K; Tomiyoshi G; Shinmen N; Nakamura R; Kuroda H; Iwadate Y; Hiwasa T
    Sci Rep; 2021 Jun; 11(1):13450. PubMed ID: 34188129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JMJD6 Autoantibodies as a Potential Biomarker for Inflammation-Related Diseases.
    Zhang BS; Zhang XM; Ito M; Yajima S; Yoshida K; Ohno M; Nishi E; Wang H; Li SY; Kubota M; Yoshida Y; Matsutani T; Mine S; Machida T; Takemoto M; Yamagata H; Hayashi A; Yokote K; Kobayashi Y; Takizawa H; Kuroda H; Shimada H; Iwadate Y; Hiwasa T
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated levels of autoantibodies against DNAJC2 in sera of patients with atherosclerotic diseases.
    Yoshida Y; Zhang XM; Wang H; Machida T; Mine S; Kobayashi E; Adachi A; Matsutani T; Kamitsukasa I; Wada T; Aotsuka A; Iwase K; Tomiyoshi G; Nakamura R; Shinmen N; Kuroda H; Takizawa H; Kashiwado K; Shin H; Akaogi Y; Shimada J; Nishi E; Ohno M; Takemoto M; Yokote K; Kitamura K; Iwadate Y; Hiwasa T
    Heliyon; 2020 Aug; 6(8):e04661. PubMed ID: 32904265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of atherosclerosis-associated serum antibodies against colony-stimulating factor 2 in predicting the onset of acute ischemic stroke and prognosis of colorectal cancer.
    Li SY; Yoshida Y; Kubota M; Zhang BS; Matsutani T; Ito M; Yajima S; Yoshida K; Mine S; Machida T; Hayashi A; Takemoto M; Yokote K; Ohno M; Nishi E; Kitamura K; Kamitsukasa I; Takizawa H; Sata M; Yamagishi K; Iso H; Sawada N; Tsugane S; Iwase K; Shimada H; Iwadate Y; Hiwasa T
    Front Cardiovasc Med; 2023; 10():1042272. PubMed ID: 36844744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum anti-PCK1 antibody levels are a prognostic factor for patients with diabetes mellitus.
    Namiki T; Takemoto M; Hayashi A; Yamagata H; Ishikawa T; Yokote K; Li SY; Kubota M; Zhang BS; Yoshida Y; Matsutani T; Mine S; Machida T; Kobayashi Y; Terada J; Naito A; Tatsumi K; Takizawa H; Nakamura R; Kuroda H; Iwadate Y; Hiwasa T
    BMC Endocr Disord; 2023 Oct; 23(1):239. PubMed ID: 37904164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum anti-SERPINE1 antibody as a potential biomarker of acute cerebral infarction.
    Kubota M; Yoshida Y; Kobayashi E; Matsutani T; Li SY; Zhang BS; Mine S; Machida T; Takizawa H; Hiwasa T; Iwadate Y
    Sci Rep; 2021 Nov; 11(1):21772. PubMed ID: 34741085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevation of Autoantibody in Patients with Ischemic Stroke.
    Yoshida Y; Hiwasa T; Machida T; Kobayashi E; Mine S; Matsushima J; Takiguchi M; Iwadate Y
    Neurol Med Chir (Tokyo); 2018 Jul; 58(7):303-310. PubMed ID: 29848906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of serum anti-periodontal pathogen antibody with ischemic stroke.
    Hosomi N; Aoki S; Matsuo K; Deguchi K; Masugata H; Murao K; Ichihara N; Ohyama H; Dobashi H; Nezu T; Ohtsuki T; Yasuda O; Soejima H; Ogawa H; Izumi Y; Kohno M; Tanaka J; Matsumoto M
    Cerebrovasc Dis; 2012; 34(5-6):385-92. PubMed ID: 23207319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum Fractalkine (CX3CL1) and Cardiovascular Outcomes and Diabetes: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Shah R; Matthews GJ; Shah RY; McLaughlin C; Chen J; Wolman M; Master SR; Chai B; Xie D; Rader DJ; Raj DS; Mehta NN; Budoff M; Fischer MJ; Go AS; Townsend RR; He J; Kusek JW; Feldman HI; Foulkes AS; Reilly MP;
    Am J Kidney Dis; 2015 Aug; 66(2):266-73. PubMed ID: 25795074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of RAGE with acute ischemic stroke prognosis in type 2 diabetes.
    Liu B; Ye X; Zhao G; Jin L; Shi J
    Ir J Med Sci; 2021 May; 190(2):625-630. PubMed ID: 32989654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of serum anti-striatin 4 antibodies as a common marker for esophageal cancer and other solid cancers.
    Ito M; Hiwasa T; Oshima Y; Yajima S; Suzuki T; Nanami T; Sumazaki M; Shiratori F; Funahashi K; Takizawa H; Kashiwado K; Tochigi N; Shimada H
    Mol Clin Oncol; 2021 Nov; 15(5):237. PubMed ID: 34650804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of specific and common diagnostic antibody markers for gastrointestinal cancers by SEREX screening using testis cDNA phage library.
    Kobayashi S; Hiwasa T; Arasawa T; Kagaya A; Ishii S; Shimada H; Ito M; Suzuki M; Kano M; Rahmutulla B; Kitamura K; Sawabe Y; Shin H; Takiguchi M; Nomura F; Matsubara H; Matsushita K
    Oncotarget; 2018 Apr; 9(26):18559-18569. PubMed ID: 29719626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum neutrophil gelatinase-associated lipocalin is associated with cardiovascular events in patients with chronic kidney disease.
    Solak Y; Yilmaz MI; Siriopol D; Saglam M; Unal HU; Yaman H; Gok M; Cetinkaya H; Gaipov A; Eyileten T; Sari S; Yildirim AO; Tonbul HZ; Turk S; Covic A; Kanbay M
    Int Urol Nephrol; 2015 Dec; 47(12):1993-2001. PubMed ID: 26498629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of antibody against wingless‑type MMTV integration site family member 7B as a biliary cancer tumor marker.
    Takahashi M; Tsuchikawa T; Hiwasa T; Nakamura T; Hontani K; Kushibiki T; Inoko K; Takano H; Hatanaka Y; Matsushita K; Matsubara H; Hoshino T; Ohtsuka M; Shimada H; Tanaka K; Nakanishi Y; Asano T; Noji T; Okamura K; Shichinohe T; Hirano S
    Oncol Rep; 2023 Feb; 49(2):. PubMed ID: 36562381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Risk Factor Control in the Year After Discharge for Ischemic Stroke Versus Acute Myocardial Infarction.
    Bravata DM; Daggy J; Brosch J; Sico JJ; Baye F; Myers LJ; Roumie CL; Cheng E; Coffing J; Arling G
    Stroke; 2018 Feb; 49(2):296-303. PubMed ID: 29284738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain natriuretic peptide in acute ischemic stroke.
    Maruyama K; Shiga T; Iijima M; Moriya S; Mizuno S; Toi S; Arai K; Ashihara K; Abe K; Uchiyama S
    J Stroke Cerebrovasc Dis; 2014; 23(5):967-72. PubMed ID: 24119617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of serum levels of antibodies against MMP1, CBX1, and CBX5 with transient ischemic attack and cerebral infarction.
    Wang H; Zhang XM; Tomiyoshi G; Nakamura R; Shinmen N; Kuroda H; Kimura R; Mine S; Kamitsukasa I; Wada T; Aotsuka A; Yoshida Y; Kobayashi E; Matsutani T; Iwadate Y; Sugimoto K; Mori M; Uzawa A; Muto M; Kuwabara S; Takemoto M; Kobayashi K; Kawamura H; Ishibashi R; Yokote K; Ohno M; Chen PM; Nishi E; Ono K; Kimura T; Machida T; Takizawa H; Kashiwado K; Shimada H; Ito M; Goto KI; Iwase K; Ashino H; Taira A; Arita E; Takiguchi M; Hiwasa T
    Oncotarget; 2018 Jan; 9(5):5600-5613. PubMed ID: 29464021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.